{
    "body": "What is the advantage of neutral loss detection in phosphoproteomics?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/21455477", 
        "http://www.ncbi.nlm.nih.gov/pubmed/16641100", 
        "http://www.ncbi.nlm.nih.gov/pubmed/18785766", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21526838", 
        "http://www.ncbi.nlm.nih.gov/pubmed/15665377", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19241031", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19504542", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19056867", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22844594", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23918812", 
        "http://www.ncbi.nlm.nih.gov/pubmed/21033674"
    ], 
    "ideal_answer": [
        "The localization of phosphorylation sites in peptide sequences is a challenging problem in large-scale phosphoproteomics analysis. The intense neutral loss peaks and the coexistence of multiple serine/threonine and/or tyrosine residues are limiting factors for objectively scoring site patterns across thousands of peptides.\nCID of phosphopeptides typically results in spectra dominated by a neutral loss of the phosphate group  allowing detection and sequencing of phosphopeptides."
    ], 
    "type": "summary", 
    "id": "550889db098a1b487b000005", 
    "snippets": [
        {
            "offsetInBeginSection": 809, 
            "offsetInEndSection": 927, 
            "text": "The higher-order fragmentations of neutral loss ions enhance the fragment ion mass spectra of phosphorylated peptides.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22844594", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1256, 
            "offsetInEndSection": 1428, 
            "text": "we identified a novel fragmentation mechanism that generates a phosphorylation site-specific neutral loss derived x-ion, which directly pinpoints the phosphorylated residue", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/21526838", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 520, 
            "offsetInEndSection": 624, 
            "text": "CID of phosphopeptides typically results in spectra dominated by a neutral loss of the phosphate group. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19504542", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 964, 
            "offsetInEndSection": 1143, 
            "text": "In this procedure we use a combination of tools to assign b-, y-, neutral loss, and internal fragment ions, with the goal of assigning all significant ions in the MS/MS spectrum. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19241031", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 555, 
            "offsetInEndSection": 777, 
            "text": "We extended the proteomic analysis to phosphoproteomic profiling using neutral loss scanning, and this yielded multiple novel phosphorylation sites, including serine-811 in the thiazide-sensitive Na-Cl co-transporter, NCC.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19056867", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 867, 
            "offsetInEndSection": 1025, 
            "text": "LC separation and MS/MS are followed by neutral loss-dependent MS/MS/MS for phosphopeptide identification using a linear ion trap (LTQ)-FT mass spectrometer. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/18785766", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 462, 
            "offsetInEndSection": 566, 
            "text": "phosphorylation site identification by liquid chromatography-mass spectrometry(n) neutral loss scanning.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/16641100", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 1356, 
            "offsetInEndSection": 1500, 
            "text": "MS/MS and neutral loss-directed MS/MS/MS analysis allowed detection and sequencing of phosphopeptides with exceptional accuracy and specificity.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/15665377", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 325, 
            "text": "The localization of phosphorylation sites in peptide sequences is a challenging problem in large-scale phosphoproteomics analysis. The intense neutral loss peaks and the coexistence of multiple serine/threonine and/or tyrosine residues are limiting factors for objectively scoring site patterns across thousands of peptides. ", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23918812", 
            "endSection": "abstract"
        }
    ]
}